Post-COVID syndrome: myth or reality

The purpose of the study: to attract the attention of pediatricians, neurologists and other specialties to the problem of the state of neurological and somatic statuses in children who have suffered SARS-COV-2. Materials and methods. A review of literature was carried out, 5 years depth of search, regarding the formation of asthenic and psychosomatic syndromes in the post -shaped period, as well as the influence of the latter on cognitive functions and the quality of life of the child. Results. In the period from December 2019 to January 2020, the world community collided with the 2019 coronavirus infection pandemia (Covid-19) caused by SARS-COV-2 Betacoronaviros. According to annual reports, the incidence is stored on high numbers. As of June 2025, 776 007 137 cases of disease were registered in the world, 7 059 612 deaths. UNICEF data indicate that children and adolescents accounted for 0.4% of all registered deaths (> 17 400 cases), of which 53% among children and adolescents 10-19 years old, 47% among children 0-9 years old. In the Russian Federation, according to information from the state report, in 2021-9.054 million cases of the disease were recorded, in 2022 12.102 million, in 2023-2.072 million, in 2024-1.125 million cases. This virus has a high degree of virulence and is capable of aggressively to affect the epithelial cells not only of the upper respiratory tract, But also the stomach, intestines, brain, which determines the variety of its clinical manifestations. Currently, in the structure of clinical manifestations, a decrease in lung lesions so, in 2021, the share of pneumonia was 22%, in 2022-4.6%, in 2023-4.1%, in 2024-3,2%. In childhood, despite the easier course, the disease is accompanied by a systemic lesion - multi -inflammatory syndrome (MVS). The penetration of the SARS-COV-2 through the hematoencephalic barrier contributes to the formation of neurological symptoms: headache, acute encephalopathy, convulsions, weakness, anosmia, etc. Most of them remain for a long period. Meanwhile, a state, which is characterized by weakness, fatigue, emotional lability, hyperesthesia, sleep disturbances and other somatovegetative manifestations, is included in the concept of asthenic syndrome. Asthenia can be observed with somatic, infectious and other diseases. The analysis of literary data emphasizes the importance of studying neurological symptoms in children who have suffered COVID-19, depending on age and require additional attention. Further studies are needed for a better understanding of these manifestations, timely diagnosis and development of effective approaches to treatment. Conclusion. The course of SARS, caused by SARS -COV -2 is accompanied by the formation of asthenic syndrome, which is one of the clinical forms of manifestation of post -shoe syndrome. Asthenia is accompanied by the depletion of energy resources, registered in all age periods, is preserved for a long time and requires correction. The study of the microcirculatory channel performed by G. NATALELLO in patients with coronavirus pneumonia and our studies of auto -regulation of intracranial blood flow after the SARS -COV -2 auto -regulation, accompanied in the first case of micro -vascular disorders in the form of microcircuctions and microtrombosis and damage to the neurovascular unity and The development of the AC is a morphological substrate formation of post -shoe syndrome in children. Thus, for the diagnosis of post -shoe syndrome, it is necessary to perform a complex of clinical and instrumental studies, which will determine approaches to rehabilitation of children who have undergone SARS -COV -2.

coronaviruses, Sars -COV -2, asthenic syndrome, post -shoe syndrome, children

1. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2024: State report. Moscow.Federal Service for Supervision of Consumer Rights Protection and Human Welfare. 2025. 424 Р. (in Russ.)@@ О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2024 году: Государственный доклад. Москва. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2025. 424 с.

2. UNICEF Data. Age-disaggregated COVID-19 confirmed cases and deaths. Available at: https://data.unicef.org/topic/child-survival/covid-19/(Accessed: 30.06.2025)

3. LaRovere K.L., Riggs B.J., Poussaint T.Y. et al; Overcoming COVID-19 Investigators. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021 May 1;78(5):536-547. doi: 10.1001/jamaneurol.2021.0504.

4. Fink E.L., Robertson C.L., Wainwright M.S. et al. Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022;128:33-44. doi: 10.1016/j.pediatrneurol.2021.12.010.

5. Antoon J.W., Hall M., Howard L.M. et al. COVID-19 and Acute Neurologic Complications in Children. Pediatrics. 2022;150(5): e2022058167. doi: 10.1542/peds.2022-058167.

6. LaRovere K.L., Poussaint T.Y., Young C.C. et al. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020. JAMA Neurol. 2023;80(1):91-98. doi: 10.1001/jamaneurol.2022.3881.

7. Misra S., Kolappa K, Prasad M. et al. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis. Neurology. 2021;97(23): e2269-e2281. doi: 10.1212/WNL.0000000000012930.

8. Mao L., Jin H., Wang M. et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.

9. Chou S.H., Beghi E., Helbok R. et al. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium. JAMA Netw Open. 2021;4(5): e2112131. Published 2021 May 3. doi: 10.1001/jamanetworkopen.2021.12131.

10. Marcolino M.S., Anschau F., Kopittke L. et al. Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort. J Neurol Sci. 2022;443:120485. doi: 10.1016/j.jns.2022.120485.

11. Ivanova R.A., Skripchenko N.V., Vishnevskaya T.V. et al. COVID-19 in children in a megalopolis: clinical, epidemiological and therapeutic aspects. Practical medicine. 2021;18(6):119-127. (in Russ.) doi: 10.32000/2072-1757-2020-6-119-127.@@ Иванова Р.A, Скрипченко Н.В., Вишневская Т.В. и др. Сovid-19 у детей в мегаполисе: клинико-эпидемиологические и терапевтические аспекты. Практическая медицина. 2021;18(6):119-127. doi: 10.32000/2072-1757-2020-6-119-127.

12. Samitova E.R. Clinical and Epidemiological Features of COVID-19 in Children in Moscow in 2020-2022. Epidemiology and Vaccinal Prevention. 2022;21(5):38-48. (In Russ.) doi: 10.31631/20733046-2022-21-5-38-48.@@ Самитова Э.Р. Клинико-эпидемиологические особенности течения COVID-19 у детей в периоды подъема заболеваемости в Москве в 2020-2022 годы. Эпидемиология и Вакцинопрофилактика. 2022;21(5):38-48. doi: 10.31631/20733046-2022-21-5-38-48.

13. Ministry of Health of the Russian Federation.Interim guidelines «Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Version 18 (26.10.2023) (in Russ.)@@ Министерство здравоохранения Российской Федерации. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 18 (26.10.2023)».

14. Isaeva E. P., Zaitseva O.V., Lokshina E.E. et al. The influence of the new coronavirus infection (COVID-19) on the level of anxiety in children. Pediatrician’s practice. 2023;1:39-44. (in Russ.)@@ Исаева Е.П., Зайцева О.В., Локшина Э.Э. и др. Влияние новой коронавирусной инфекции (COVID-19) на уровень тревожности у детей. Практика педиатра. 2023;1:39-44.

15. Rusetsky Y.Y., Meitel I. Yu., Babayan A.R., Malyavina U.S. Otorhinolaryngological aspects of the course of the disease in children infected with the SARS-CoV-2 virus. Bulletin of otorhinolaryngology. 2020;85(2):63-66. (in Russ.)@@ Русецкий Ю.Ю., Мейтель И.Ю., Бабаян А.Р., Малявина У.С. Оториноларингологические аспекты течения заболевания у детей, инфицированных вирусом SARS-CoV-2. Вестник оториноларингологии. 2020;85(2):63-66.

16. Volodin N.N., Khasanova K.A., Gorbunov A.V., Vykhristyuk O.F., Degtyareva M.V., Erokhina A.V., Korochkina E.S. Neurological Aspects of COVID-19 in Children and Adolescents: Literature Review and Case Series. Medical practice. 2023;(4):103-113. (in Russ.) doi: 10.24412/2071-5315-2023-13032.@@ Володин Н.Н., Хасанова К.А., Горбунов А.В., Выхристюк О.Ф., Дегтярева М.В., Ерохина А.В., Корочкина Е.С. Неврологические аспекты COVID-19 у детей и подростков: обзор литературы и описание серии случаев. Лечебное дело. 2023;(4):103-113. doi: 10.24412/2071-5315-2023-13032.

17. Kholin A.A., Zavadenko N.N., Nesterovskiy Yu.E., Kholina E.A., Zavadenko A.N., Khondkaryan G. Sh. Features of neurological manifestations of the COVID-19 in children and adults. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2020;120(9):114-120. (In Russ.) doi: 10.17116/jnevro2020120091114.@@ Холин А.А., Заваденко Н.Н., Нестеровский Ю.Е., Холина Е.А., Заваденко А.Н., Хондкарян Г.Ш. Особенности неврологических проявлений COVID-19 у детей и взрослых. Журнал неврологии и психиатрии им. С.С. Корсакова. 2020;120(9):114-120. doi: 10.17116/jnevro2020120091114.

18. Cruz A.T., Zeichner S.L. COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics. 2020;145(6):20200834. doi: 10.1542/peds.2020-0834.

19. Xia W., Shao J., Guo Y. et al. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatrics Pulmonol. 2020;55(5):1169-1174. doi: 10.1002/ppul.24718.

20. Hoang A., Chorath K., Moreira A. et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020;(24):100433. doi: 10.1016/j.eclinm.2020.100433.

21. Tagarro A., Epalza С., Santos М. et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatr. 2020;174(10):1009. doi: 10.1001/jamapediatrics.2020.1528.

22. Molteni Е., Astley C.M., Ma W. et al. Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts. Sci Rep. 2021;11(1):6928. doi: 10.1038/s41598-021-86452-3.

23. Nextstrain. Real-time tracking of pathogen evolution. Available at: https://nextstrain.org Accessed: 24.01.2025.

24. Xu X., Wu Y., Kummer A.G. et al. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta- analysis. BMC Med. 2023;21(1):374. doi: 10.1186/s12916-023-03070-8.

25. Tracking SARS-CoV-2 variants. WHO. Available at: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants Accessed: 24.01.2025.

26. Geismar С., Nguyen V., Fragaszy E. et al. Symptom profiles of community cases infected by influenza, RSV, rhinovirus, seasonal coronavirus, and SARS-CoV-2 variants of concern. Sci Rep. 2023;(13):12511. doi: 10.1038/s41598-023-38869-1.

27. Feldblum I.V., Devyatkov M. Yu., Repin T.M. et al. Variability of the SARS-CoV-2 virus and population susceptibility in the dynamics of the epidemic process. Epidemiology and Vaccine prevention. 2023;22(5):4-11. (in Russ.) doi: 10.31631/2073-3046-2023-22-5-4-11.@@ Фельдблюм И.В., Девятков М.Ю., Репин Т.М. и др. Изменчивость вируса SARS-CoV-2 и восприимчивости населения в динамике развития эпидемического процесса. Эпидемиология и Вакцинопрофилактика. 2023;22(5):4-11. doi: 10.31631/2073-3046-2023-22-5-4-11.

28. Kaleda M.I. et al. Coronavirus disease 2019 (COVID-19) in children: lessons in pediatric rheumatology. Scientific and Practical Rheumatology. 2020;658(5):469-479. (in Russ.)@@ Каледа М.И. и др. Коронавирусная болезнь 2019 (COVID-19) у детей: уроки педиатрической ревматологии. Научно-практическая ревматология. 2020;58(5):469-479.

29. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Scientific Brief. WHO. Available at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 (Accessed: 25.09.2024).

30. Yonker L.M., Gilboa T., Ogata A.F. et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021;131(14): e149633. doi: 10.1172/JCI149633.

31. Zakharova I.N., Tvorogova T.M., Pshenichnikova I.I. Asthenic syndrome in schoolchildren: from the risk of development to diagnosis and treatment. Pediatrics. Consilium Medicum. 2021; 1. (in Russ.) doi: 10.26442/26586630.2021.1.200713.@@ Захарова И.Н., Творогова Т.М., Пшеничникова И.И. Астенический синдром у школьников: от риска развития до диагностики и лечения. Педиатрия. Consilium Medicum. 2021; 1. doi: 10.26442/26586630.2021.1.200713.

32. Shchederkina I.O., Ovsyannikov D. Yu., Glazyrina A.A., Ivin N.O., Bronina N.V., Kuznetsova A.A., Gorev V.V. Asthenic syndrome in children and adolescents: choice of therapy. Nervous diseases. 2021; (2): 20-28. (in Russ.) doi: 10.24412/2226-0757-2021-12322.@@ Щедеркина И.О., Овсянников Д.Ю., Глазырина А.А., Ивин Н.О., Бронина Н.В., Кузнецова А.А., Горев В.В. Астенический синдром у детей и подростков: выбор терапии. Нервные болезни. 2021; (2): 20-28. doi: 10.24412/2226-0757-2021-12322.

33. Nisovtseva O.A. Asthenic Syndrome in children. Hard to beat patient. 2022;20 (1):39-43. (in Russ.) doi: 10.224412/2074-1005-2022-1-39-43.@@ Низовцева О.А. Астенический синдром у детей. Трудный пациент. 2022;20 (1):39-43. doi: 10.224412/2074-1005-2022-1-39-43.

34. Chutko L.S., Kornishina T.L., Surushkina S. Yu. et al. Autonomic dysfunction syndrome in children and adolescents. Journal of Neurology and Psychiatry. 2018;(1):43-9. (in Russ.)@@ Чутко Л.С., Корнишина Т.Л., Сурушкина С.Ю. и др. Синдром вегетативной дисфункции у детей и подростков. Журнал неврологии и психиатрии. 2018; (1): 43-9.

35. Mazankova L.N., Samitova E.R., Osmanov I.M. et al. COVID-19 and comorbid pathology in children. Issues of practical pediatrics. 2022;17(1):16-23. (in Russ.) doi: 10.20953/1817-7646-2022-1-16-23.@@ Мазанкова Л.Н., Самитова Э.Р., Османов И.М. и др. COVID-19 и коморбидная патология у детей. Вопросы практической педиатрии. 2022;17(1):16-23. doi: 10.20953/1817-7646-2022-1-16-23.

36. Shkarin V.V., Kovalishena O.V., Sergeeva A.V., Murtayeva A.A. Aspects of comorbidity in children with COVID-19. Childhood infections. 2023;22(2):49-55. (in Russ.) doi: 10.22627/2072-8107-2023-22-2-49-55.@@ Шкарин В.В., Ковалишена О.В., Сергеева А.В., Муртаева А.А. Аспекты коморбидности у детей с COVID-19. Детские инфекции. 2023;22(2):49-55. doi: 10.22627/2072-8107-2023-22-2-49-55.

37. Davis H.E., McCorkell L., Vogel J.M. et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133-146. doi: 10.1038/s41579-022-00846-2.

38. Ha E.K., Kim J.H., Han M.Y. Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies. Clin Exp Pediatr. 2023;66(11):465-474. doi: 10.3345/cep.2023.00472.

39. Degtyareva E.A., Gorelov A.V., Simonovskaya H.Y. et al. Cardiac and autonomic manifestations of long-COVID in children. Issues of practical pediatrics. 2022;17(5):75-82. (in Russ.) doi: 10.20953/1817-7646-2022-5-75-82.@@ Дегтярева Е.А., Горелов А.В., Симоновская Х.Ю. и др. Кардиальные и вегетативные проявления long-COVID у детей. Вопросы практической педиатрии. 2022;17(5):75-82. doi: 10.20953/1817-7646-2022-5-75-82.

40. Volodin N.N., Khasanova K.A., Gorbunov A.V., Vykhristyuk O.F., Degtyareva M.V., Erokhina A.V., Kurochkina E.S. Neurological Aspects of COVID-19 in Children and Adolescents: Literature Review and Case Series. Medical Business. 2023;(4):103-113. (in Russ.) doi: 10.24412/2071-5315-2023-13032.@@ Володин Н.Н., Хасанова К.А., Горбунов А.В., Выхристюк О.Ф., Дегтярева М.В., Ерохина А.В., Курочкина Е.С. Неврологические аспекты COVID-19 у детей и подростков: обзор литературы и серия случаев. Медицинский бизнес. 2023;(4):103-113. doi: 10.24412/2071-5315-2023-13032.

41. Tsarikova S.A., Zaitseva O.V., Lokshina Y.Y. et al. Postcovidexposure syndrome in children: the outcome of the repeatedmementialmentialexample. Pediatrics. Consilium Medicum. 2024;(1):55-63. (in Russ.) doi: 10.26442/26586630.2024.1.202688.@@ Царькова С.А., Зайцева О.В., Локшина Э.Э. и др. Постковидный синдром у детей: результаты ретроспективного мультицентрового одномоментного исследования. Педиатрия. Consilium Medicum. 2024;(1):55-63. doi: 10.26442/26586630.2024.1.202688.

42. Guido C.A., Lucidi F., Midulla F. et al. Neurological and psychological effects of long COVID in a young population: A cross-sectional study. Front Neurol. 2022;(13):925144. doi: 10.3389/fneur.2022.925144.

43. Saini L., Krishna D., Tiwari S. et al. Post-COVID-19 Immune-Mediated Neurological Complications in Children: An Ambispective Study. Pediatr Neurol. 2022;(136):20-27. doi: 10.1016/j.pediatrneurol.2022.06.010.

44. Fogarty H., Townsend L., Morrin H. et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546-2553. doi: 10.1111/jth.15490.

45. Mikheeva I.G., Kurasova O.B., Milekhina M.Y. et al. Analysis of the state of the microvascular bed and planning of rehabilitation measures in children after a new coronavirus infection. Breast cancer. Mother and child. 2024;7(2):171-176. (in Russ.) doi: 10.32364/2618-8430-2024-7-2-13.@@ Михеева И.Г., Курасова О.Б., Милехина М.Ю. и др. Анализ состояния микрососудистого русла и планирование реабилитационных мероприятий у детей после перенесенной новой коронавирусной инфекции. РМЖ. Мать и дитя. 2024;7(2):171-176. doi: 10.32364/2618-8430-2024-7-2-13.

46. Fonyakin A.V., Mashin V.V., Atayan A.S. et al. Cerebral circulation, neurological and neuropsychological disorders in idiopathic arterial hypotension. Neurology, neuropsychiatry, psychosomatics. 2011;(4):50-55. (in Russ.)@@ Фонякин А.В., Машин В.В., Атаян А.С. и др. Церебральное кровообращение, неврологические и нейропсихологические расстройства при идиопатической артериальной гипотензии. Неврология, нейропсихиатрия, психосоматика. 2011;(4):50-55.

47. Pykov M.I. Pediatric ultrasound diagnostics. Volumes 1-5. Volume 3. Neurology. Vessels of the head and neck. 2014-2021. Vidar-Moscow. (in Russ.)@@ Пыков М.И. Детская ультразвуковая диагностика. Тома 1-5. Том 3. Неврология. Сосуды головы и шеи. 2014-2021. Видар-Москва.

48. Pankov D.D., Pankova T.B., Kovrigina E.S., Klyuchnikova I.V. Diagnosis of asthenic syndrome in schoolchildren and methods of its correction. RMJ. Medical Review. 2019; 3:45-50. (in Russ.)@@ Панков Д.Д., Панкова Т.Б., Ковригина Е.С., Ключникова И.В. Диагностика астенического синдрома у школьников и методы его коррекции. РМЖ. Медицинское обозрение. 2019; 3: 45-50.

49. Natalello G., De Luca G., Gigante L. et al. Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. Microvasc Res. 2021;(133):104071. doi: 10.1016/j.mvr.2020.104071.